The treatment, called ivonescimab, has become a symbol of China’s rise in drug development.
Category: Summit Therapeutics Inc
-
F.D.A. Rejects Closely Watched Lung Cancer Drug From China
The New York Times – Business:

The treatment, called ivonescimab, has become a symbol of China’s rise in drug development.